PRIMARY CENTRAL CHONDROSARCOMA

Clinical trials for PRIMARY CENTRAL CHONDROSARCOMA explained in plain language.

Never miss a new study

Get alerted when new PRIMARY CENTRAL CHONDROSARCOMA trials appear

Sign up with your email to follow new studies for PRIMARY CENTRAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug tested for rare, Hard-to-Treat bone cancer

Disease control Ongoing

This study tested an oral drug called vismodegib in patients with advanced chondrosarcoma, a rare type of bone cancer that has spread and is difficult to treat. The main goal was to see if the drug could stop the cancer from growing for at least six months. Researchers also track…

Matched conditions: PRIMARY CENTRAL CHONDROSARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PRIMARY CENTRAL CHONDROSARCOMA

Get alerted when new PRIMARY CENTRAL CHONDROSARCOMA trials appear

New drug tested for rare, Hard-to-Treat bone cancer